Core Viewpoint - CarMax, Inc. is facing a class action lawsuit for securities fraud following a significant drop in its stock price, attributed to alleged violations of federal securities laws [2][4]. Group 1: Lawsuit Details - A class action lawsuit has been filed against CarMax and certain senior executives, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [4]. - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [4]. Group 2: Financial Performance - CarMax reported disappointing financial results for Q2 of fiscal year 2026, with a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [7]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million in the previous year [7]. Group 3: Stock Price Impact - Following the announcement of disappointing financial results on September 25, 2025, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 to $45.60 [8]. - The unexpected departure of CEO Bill Nash on November 6, 2025, along with a weak preliminary Q3 outlook, led to an additional stock price drop of over 24% [8]. Group 4: Market Context - CarMax had previously promoted strong demand for its vehicles, which was allegedly boosted by a short-term increase in purchases due to U.S. tariffs on cars [5]. - The lawsuit also investigates whether CarMax properly assessed or reserved for its portfolio of car loans following the CEO's departure [6].

MLTX COURT ALERT: MoonLake Immunotherapeutics Investors are Notified the Compay has been Sued for Securities Fraud and are Notified to Contact BFA Law by December 15December 02, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - December 2, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violat ...

JHX COURT ALERT: James Hardie Industries plc Investors are Notified the Company has been Sued for Securities Fraud and are Notified to Contact BFA Law by December 23December 02, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - December 2, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securi ...

Core Viewpoint - Stride, Inc. is facing a class action lawsuit for securities fraud, which has led to significant stock price drops due to alleged violations of federal securities laws [2][4]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [5]. Allegations and Impact - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students" and ignored compliance requirements, leading to a poor customer experience and higher withdrawal rates [5][6]. - Stride's stock dropped by $18.60 (over 11%) on September 15, 2025, following the announcement of the fraud complaint, and further plummeted by $83.48 (over 54%) on October 29, 2025, after admitting to poor customer experiences that resulted in 10,000-15,000 fewer enrollments [6][7]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [4]. - The lawsuit is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [4]. Investor Actions - Investors are encouraged to seek additional information and may have legal options available to them [3][9].

FCX COURT ALERT: Freeport-McMoRan Inc. Investors are Notified the Company has been Sued for Securities Fraud and are Notified to Contact BFA Law by January 12December 02, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - December 2, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud af ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Bath & Body Works, Inc. ("Bath & Body Works†or the "Company†) (NYSE: BBWI) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BATH & BODY WORKS, INC. (BBWI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to di. ...

RADNOR, Pa., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Varonis Systems, Inc. (NASDAQ: VRNS) (“Varonis”). On October 28, 2025, Varonis reported its financial results for the third quarter of 2025 and revealed revenue which missed consensus estimates, including a 63.9% decline in term license subscription revenues, year over year. Varonis also discl ...

Core Viewpoint - The James Hardie Industries plc is facing a class action lawsuit due to allegations of misleading investors regarding the performance of its North America Fiber Cement segment, which reportedly experienced significant inventory destocking and a subsequent decline in sales [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled "Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc" and is filed in the Northern District of Illinois [1]. - Investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, can seek appointment as lead plaintiff until December 23, 2025 [1][5]. - The lawsuit alleges that James Hardie and its executives violated the Securities Exchange Act of 1934 by making false statements about the strength of their business segment [1][3]. Group 2: Allegations Against James Hardie - The lawsuit claims that despite early signs of inventory destocking in April and May 2025, James Hardie continued to assure investors of strong performance, misleading them about actual sales conditions [3]. - On August 19, 2025, James Hardie disclosed a 12% decline in sales for the North America Fiber Cement segment, which led to a stock price drop of over 34% [4]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased James Hardie common stock during the class period to seek lead plaintiff status, which involves directing the lawsuit on behalf of all class members [5]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is recognized as a leading firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [6].

PHILADELPHIA, Dec. 2, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix" or the "Company") on behalf of investors who purchased Telix securities during the period of February 21, 2025 through August 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Telix securities during the Class Period may, no later than January 9, 2026, seek to be appointed as a le ...

Dec 2, 2025 12:23 PM Eastern Standard Time SFM Investors Have Opportunity to Lead Sprouts Farmers Market, Inc. Securities Fraud Lawsuit with the Schall Law Firm Share LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sprouts Farmers Market, Inc. ("Sprouts†or "the Company†) (NASDAQ: SFM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U. ...